Global Kidney Fibrosis Treatment Market Size, Share, Trends, Growth and Forecast 2032

Kidney Fibrosis Treatment Market

Kidney Fibrosis Treatment Market - By Therapeutics (Angiotensin II Receptor Blockers, Angiotensin Converting Enzyme Inhibitors, Renin Inhibitors, Pirfenidone, and Vasopeptidase Inhibitors), By Location Of Testing (Commercial/Private Hospitals, Hospital Testing, Clinics, Public Health Hospitals, and Home Treatment), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2989 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 4.78 Billion USD 7.65 Billion 4.8% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
    • 2.2. Kidney Fibrosis Treatment Market: Snapshot
  • Chapter 3. Global Kidney Fibrosis Treatment Market– Industry Analysis
    • 3.1. Kidney Fibrosis Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating occurrence of chronic disorders due to unhealthy food habits has resulted in kidney fibrosis cases, thereby culminating into huge market demand in the upcoming years.
      • 3.2.2. Surge in the aging population along with massive awareness pertaining to renal fibrosis therapy will prompt the kidney fibrosis market expansion over the forthcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Therapeutics
      • 3.4.2. Market attractiveness analysis By Material
  • Chapter 4. Global Kidney Fibrosis Treatment Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Kidney Fibrosis Treatment Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Kidney Fibrosis Treatment Market– Therapeutics Analysis
    • 5.1. Global Kidney Fibrosis Treatment Market overview: By Therapeutics
      • 5.1.1. Global Kidney Fibrosis Treatment Market share, By Therapeutics , 2019 and 2025
    • 5.2. Angiotensin II Receptor Blockers
      • 5.2.1. Global Kidney Fibrosis Treatment Market By Angiotensin II Receptor Blockers , 2015–2025 (USD Billion)
    • 5.3. Angiotensin Converting Enzyme Inhibitors
      • 5.3.1. Global Kidney Fibrosis Treatment Market By Angiotensin Converting Enzyme Inhibitors, 2015–2025 (USD Billion)
    • 5.4. Renin Inhibitors
      • 5.4.1. Global Kidney Fibrosis Treatment Market By Renin Inhibitors , 2015–2025 (USD Billion)
    • 5.5. Pirfenidone
      • 5.5.1. Global Kidney Fibrosis Treatment MarketBy Pirfenidone, 2015–2025 (USD Billion)
    • 5.6. Vasopeptidase Inhibitors
      • 5.6.1. Global Kidney Fibrosis Treatment MarketBy Vasopeptidase Inhibitors, 2015–2025 (USD Billion)
  • Chapter 6. Global Kidney Fibrosis Treatment Market– Location of Testing Analysis
    • 6.1. Global Kidney Fibrosis Treatment Market overview: By Location of Testing
      • 6.1.1. Global Kidney Fibrosis Treatment Market share, By Location of Testing , 2019 and 2025
    • 6.2. Commercial/Private Hospitals
      • 6.2.1. Global Kidney Fibrosis Treatment Market By Commercial/Private Hospitals, 2015–2025 (USD Billion)
    • 6.3. Hospital Testing
      • 6.3.1. Global Kidney Fibrosis Treatment Market By Hospital Testing, 2015–2025 (USD Billion)
    • 6.4. Clinics
      • 6.4.1.1. Global Kidney Fibrosis Treatment Market By Clinics, 2015–2025 (USD Billion)
    • 6.5. Public Health Hospitals
      • 6.5.1.1. Global Kidney Fibrosis Treatment Market By Public Health Hospitals, 2015–2025 (USD Billion)
    • 6.6. Home Treatment
      • 6.6.1.1. Global Kidney Fibrosis Treatment Market By Home Treatment, 2015–2025 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. F. Hoffman-La Roche Ltd.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Service Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Merck & Co.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Service Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Galectin Therapeutics
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Service Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Pfizer Inc.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Service Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. InterMune Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Service Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. La Julla Pharmaceutical Company
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Service Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Genzyme Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Service Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. ProMetic Life-Sciences Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Service Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. BioLine Rx Ltd
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Service Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Kidney Fibrosis Treatment Market attractiveness, By Therapeutics 
6. Global Kidney Fibrosis Treatment Market attractiveness, By Location of Testing
7. Global Kidney Fibrosis Treatment Market Share by Therapeutics ,2019 and 2025 (USD Billion)
8. Global Kidney Fibrosis Treatment Market by Angiotensin II Receptor Blockers ,2015–2025 (USD Billion)
9. Global Kidney Fibrosis Treatment Market by Angiotensin Converting Enzyme Inhibitors ,2015–2025 (USD Billion)
10. Global Kidney Fibrosis Treatment Market by Renin Inhibitors ,2015–2025 (USD Billion)
11. Global Kidney Fibrosis Treatment Market by Pirfenidone ,2015–2025 (USD Billion)
12. Global Kidney Fibrosis Treatment Market by Vasopeptidase Inhibitors ,2015–2025 (USD Billion)
13. Global Kidney Fibrosis Treatment Market Share by Location of Testing,2019 and 2025 (USD Billion)
14. Global Kidney Fibrosis Treatment Market by Commercial/Private Hospitals,2015–2025 (USD Billion)
15. Global Kidney Fibrosis Treatment Market by Hospital Testing,2015–2025 (USD Billion)
16. Global Kidney Fibrosis Treatment Market by Clinics,2015–2025 (USD Billion)
17. Global Kidney Fibrosis Treatment Market by Public Health Hospitals,2015–2025 (USD Billion)
18. Global Kidney Fibrosis Treatment Market by Home Treatment,2015–2025 (USD Billion)
19. Global Kidney Fibrosis Treatment Market share, by Region, 2019 and 2025
20. North America Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
21. Europe Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
22. Asia Pacific Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
23. Latin America Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
24. The Middle East and Africa Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)


Table Of Tables

List of Tables

1. Global Kidney Fibrosis Treatment Market: snapshot
2. Drivers of the Kidney Fibrosis Treatment Market: impact analysis
3. North America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
4. North America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
5. The U.S. Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
6. The U.S. Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
7. Rest of North America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
8. Rest of North America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
9. Europe Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
10. Europe Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
11. UK Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
12. UK Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
13. France Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
14. France Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
15. Germany Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
16. Germany Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
17. Rest of Europe Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
18. Rest of Europe Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
19. Asia Pacific Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
20. Asia Pacific Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
21. China Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
22. China Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
23. Japan Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
24. Japan Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
25. India Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
26. India Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
27. Rest of Asia Pacific Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
28. Rest of Asia Pacific Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
29. Latin America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
30.  Latin America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
31. Brazil Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
32. Brazil Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
33. Rest of Latin America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
34. Rest of Latin America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
35. The Middle East and Africa Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
36. The Middle East and Africa Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
37. Saudi Arabia Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
38. Saudi Arabia Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
39. South Africa Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
40. South Africa Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
41. Rest of the Middle East & Africa Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
42. Rest of the Middle East & Africa Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)


 
 

Methodology

FrequentlyAsked Questions

Kidney fibrosis treatment aims to slow or reverse kidney scarring. It helps preserve kidney function

The global Kidney Fibrosis Treatment market is expected to be driven by the rising chronic kidney disease cases and unmet medical needs. Advancements in targeted therapies and increased research funding support market growth.

According to study, the global Kidney Fibrosis Treatment market size was worth around USD 4.78 Billion in 2023 and is predicted to grow to around USD 7.65 Billion By 2032.

The global Kidney Fibrosis Treatment market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 4.8% during the forecast period from 2024-2032.

The global Kidney Fibrosis Treatment industry is projected to be challenged by Challenges include limited approved therapies, complex disease progression, and long clinical trials.

The Opportunities include rising CKD prevalence, novel drug pipelines, biomarker research, and orphan drug incentives will offer significant growth opportunities in the Kidney Fibrosis Treatment market.

Anti-fibrotic drug development; regenerative and cell-based therapies; biomarker-led early diagnosis and trials are the emerging trends and innovations impacting the Kidney Fibrosis Treatment market.

The global Kidney Fibrosis Treatment market is expected to be led by North America during the forecast period.

Some of the prominent players operating in the global Kidney Fibrosis Treatment market are; InterMune Inc., Merck & Co., Pfizer Inc., La Jolla Pharmaceutical Company, F. Hoffman-La Roche Ltd., Galectin Therapeutics, BioLine Rx Ltd., Genzyme Corporation, and ProMetic Life-Sciences Inc and others.

The report explores crucial aspects of the Kidney Fibrosis Treatment market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

What is the Market Size?IntroductionMarket Growth DriversReport ScopeMarket, By TherapeuticMarket, By End-UserMarket, By GeographyNorth America To Erupt As Global Market Leader During Forecast TimeframeKey participants profiled in the report are:The global kidney fibrosis treatment market is segmented as follows:

HappyClients